“It is great to have long term follow up on this large, adjudicated GCP study. At this time, there is no device that has been shown to be safer for aneurysm patients than WEB. So, if a patient with a wide-neck bifurcation aneurysm can be treated with WEB, that ought to be the primary consideration,”… Read More
The board of directors of The University of Tennessee Medical Center (UTMC) has selected Dr. Keith Gray as president and chief executive officer, effective April 1, 2024. Dr. Gray succeeds Joseph “Joe” Landsman, Jr., who today announced his retirement after 25 years with the system. In connection with the transition, Dr. James Shamiyeh, who currently… Read More
The University of Tennessee Health Science Center (UTHSC), oncology drug discovery research partner to Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of breast cancer and for SARS-CoV-2 and other viral ARDS-related diseases, has secured two additional grants to develop oncology therapeutics for indications of… Read More
Le Bonheur Children’s Hospital, in partnership with the Ryan Seacrest Foundation, opened a new state-of-the-art 1,275 square-foot broadcast media center called Seacrest Studio on Wednesday. As the primary pediatric teaching affiliate for the University of Tennessee Health Science Center, Le Bonheur trains more than 350 pediatricians and specialists each year.
The use of chatbots and natural language processing technology, such as ChatGPT, has the potential to change the future of medical writing —with some caveats— says Som Biswas, MD, a Radiology fellow at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center, in an article published in Radiology. The published article was written entirely by ChatGPT… Read More
Provectus (OTCQB: PVCT) today announced that preclinical research on the Company’s pharmaceutical-grade rose bengal sodium drug substance against colistin-resistant gram-negative (G-) bacteria was published in The Journal of Antibiotics, a medical periodical by Nature Portfolio for the Japan Antibiotics Research Association. Colistin is used as a last-resort treatment for infections when other drugs fail. The World… Read More
Kevin Foley, MD, Chairman of Semmes-Murphey Neurologic and Spine Institute and professor of neurosurgery, orthopedic surgery and biomedical engineering at the University of Tennessee Health Science Center stated, “The Inspire porous PEEK technology checks all of the boxes for an ideal interbody implant: fully interconnected porosity, modulus of elasticity equivalent to cancellous bone, strong biomechanical… Read More
Cellworks Group Inc., a leader in Precision Drug Development and Personalized Therapy Biosimulation, today announced results from a study that examined how Differentiation Scoring (DS) derived from key myeloid biomarkers in individual Myelodysplastic Syndrome (MDS) patients using the Cellworks Platform and Computational Biology Model (CBM) can predict response to Hypomethylating Agents (HMA). “MDS patients typically… Read More
